Verition Fund Management
ANAB icon

Verition Fund Management’s AnaptysBio ANAB Stock Holding History

Verition Fund Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22,036
Closed -$738K – 3228
2024
Q3 		$738K Buy
+22,036
New +$753K ﹤0.01% 2087
2024
Q2 		– Sell
-13,472
Closed -$303K – 2963
2024
Q1 		$303K Buy
+13,472
New +$319K ﹤0.01% 2294
2023
Q3 		– Sell
-24,380
Closed -$496K – 2327
2023
Q2 		$496K Buy
+24,380
New +$494K 0.01% 1245

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Verition Fund Management's ANAB Position: Q4 2024 in Review

Verition Fund Management sold out of AnaptysBio (ANAB) in Q4 2024, closing a stake of 22,036 shares — an estimated $738K sold.

Verition Fund Management first reported a position in ANAB in Q2 2023 and held it in 3 quarters. The position peaked at $738K in Q3 2024. 135 funds tracked by Wall St. Rank hold ANAB as of Q4 2024.

  • Verition Fund Management reported no remaining AnaptysBio position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 22,036 AnaptysBio shares in Q4 2024, an estimated $738K.
  • Verition Fund Management first reported a position in AnaptysBio in Q2 2023 and held it in 3 quarters.
  • Verition Fund Management's AnaptysBio position peaked at $738K in Q3 2024.
  • 135 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.